Pharmigene (Taipei) received GMP certification and added UniPharma Co., Ltd. DR70 registration item C.6010 (Verified by: ITRI Measurement Center).
Pharmigene obtained ISO approval to expand the capability of the following: Design and manufacture of gene detection kit and ELISA kit for clinical use.
Pharmigenen launched IVD products for the detection of HLA-B27.
Pharmigene assisted UniPharma Co. to obtain an IVD license for DR-70 from the Ministry of Health and Welfare, Taiwan.
